𝔖 Bobbio Scriptorium
✦   LIBER   ✦

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer

✍ Scribed by Anne Roslind; Ann S. Knoop; Maj-Britt Jensen; Julia S. Johansen; Dorte L. Nielsen; Paul A. Price; Eva Balslev

Publisher
Springer US
Year
2007
Tongue
English
Weight
461 KB
Volume
112
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p27Kip1 is a predictive factor for tamox
p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients
✍ Maria Stendahl; Sofie Nilsson; Caroline Wigerup; Karin Jirström; Per Ebbe Jönsso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 489 KB

## Abstract The cell‐cycle regulating protein p27^Kip1^ (p27) has dual roles by acting as both a cdk inhibitor and as an assembly factor for different cdk complexes. Loss of p27 has been linked to malignant features in tumours; however, the exact role of p27 deregulation in breast cancer regarding

Hypoxia inducible factor-1α is a prognos
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
✍ Åsa Kronblad; Karin Jirström; Lisa Rydén; Bo Nordenskjöld; Göran Landberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 765 KB

## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting

High ID2 protein expression correlates w
High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells
✍ Maria Stighall; Christina Manetopoulos; Håkan Axelson; Göran Landberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 419 KB

## Abstract ID proteins have been implicated in the regulation of cell proliferation and differentiation in various cell types during normal development as well as in the formation of cancer. Our aim was to delineate the expression of ID2 by immunohistochemistry in primary breast cancer in order to